Media
Explore our latest news, events, and resources.
From educational publications to campaign highlights and upcoming activities, this section brings together all our updates to keep patients, healthcare professionals, and advocates informed and engaged in the world of radioligand therapy.
News
- News29.08.2020
Sirtex Medical and China Grand Pharmaceutical milestone
Read more - News26.08.2020
Efficacy and safety of Ac-225-PSMA-617 TAT in Prostate Cancer
Read more - News20.08.2020
Astatine is a chemistry puzzle that shows anticancer promise
Read more - News12.08.2020
This is not a simple flower, this is an Oncidium
Read more - News12.08.2020
Webinar Theranostics and PET Imaging Diagnostics
Read more - News06.08.2020
Theranostics continue to gain momentum
Read more
Events
- EventsFebruary 08-12, 2024
Meet Camille at the 19th ICRT 2024
Read more - EventsJanuary 18-19, 2024
2024 PSMA Conference
Read more - EventsNovember 15-18, 2023
A patient session at the ALASBIMN 2023
Read more - EventsNovember 2-5, 2023
Don't miss out Alice's presentation at EMUC23
Read more - EventsOctober 20-24, 2023
Meet Alice at the ESMO Congress 2023
Read more - EventsOctober 12-13, 2023
3rd ICPO Forum
Read more
Videos
What Are Radiotheranostics for Cancer Care?
Doctor, will Radiotheranostics make me radioactive?
Tom, treated with PRRT for NETs
Fernando Acosta’s Testimonial with Lutetium-177 PSMA Radioligand Therapy
Links
Nuclear medicine
- The NME (Nuclear medicine Europe) has implemented a website for the general public called “What is Nuclear medicine ?”, that features movies, cartoons and special small booklets to be downloaded that explain basic concepts.
- Official bodies such as EANM and SNMMI also have materials explaining aria-describedby="qtip-67">Nuclear medicine.
- You will find useful information as well on the IAEA website about Radiopharmaceuticals production and some interesting Publications regarding advances search.
Books
In order to explain this technology in an accessible way, a reference booklet containing information on Nuclear medicine was written by the author of this project. It was initially intended for workers in the Radiopharmaceutical industry but was then used for patients and finally distributed to potential investors. This book is presently available in French, English, and Spanish.